These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9814434)

  • 41. ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver.
    Banda M; Recio L; Parsons BL
    Environ Mol Mutagen; 2013 Oct; 54(8):659-67. PubMed ID: 24038307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allele-specific, non-extendable primer blocker PCR (AS-NEPB-PCR) for DNA mutation detection in cancer.
    Wang H; Jiang J; Mostert B; Sieuwerts A; Martens JW; Sleijfer S; Foekens JA; Wang Y
    J Mol Diagn; 2013 Jan; 15(1):62-9. PubMed ID: 23159590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of MutS protein with the major and minor grooves of a heteroduplex DNA.
    Biswas I; Hsieh P
    J Biol Chem; 1997 May; 272(20):13355-64. PubMed ID: 9148958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence of H-ras codon 61 CAA to AAA mutation during mouse liver tumor progression.
    Parsons BL; Culp SJ; Manjanatha MG; Heflich RH
    Carcinogenesis; 2002 Jun; 23(6):943-8. PubMed ID: 12082015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency.
    Parsons BL; Delongchamp RR; Beland FA; Heflich RH
    Mutagenesis; 2006 Jan; 21(1):29-34. PubMed ID: 16314341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation detection by mismatch binding protein, MutS, in amplified DNA: application to the cystic fibrosis gene.
    Lishanski A; Ostrander EA; Rine J
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2674-8. PubMed ID: 7511817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MutS binding protects heteroduplex DNA from exonuclease digestion in vitro: a simple method for detecting mutations.
    Ellis LA; Taylor GR; Banks R; Baumberg S
    Nucleic Acids Res; 1994 Jul; 22(13):2710-1. PubMed ID: 7518920
    [No Abstract]   [Full Text] [Related]  

  • 48. Genotypic selection methods for the direct analysis of point mutations.
    Parsons BL; Heflich RH
    Mutat Res; 1997 Oct; 387(2):97-121. PubMed ID: 9372853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photocross-linking of the NH2-terminal region of Taq MutS protein to the major groove of a heteroduplex DNA.
    Malkov VA; Biswas I; Camerini-Otero RD; Hsieh P
    J Biol Chem; 1997 Sep; 272(38):23811-7. PubMed ID: 9295328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel applications of polymerase chain reaction to urinary nucleic acid analysis.
    Lichtenstein AV; Melkonyan HS; Tomei LD; Umansky SR
    Methods Mol Biol; 2006; 336():145-54. PubMed ID: 16916260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid method for detection of point mutations using mismatch binding protein (MutS) and an optical biosensor.
    Gotoh M; Hasebe M; Ohira T; Hasegawa Y; Shinohara Y; Sota H; Nakao J; Tosu M
    Genet Anal; 1997 Jul; 14(2):47-50. PubMed ID: 9349940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyrosequencing®-Based Identification of Low-Frequency Mutations Enriched Through Enhanced-ice-COLD-PCR.
    How-Kit A; Tost J
    Methods Mol Biol; 2015; 1315():83-101. PubMed ID: 26103893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approaches to DNA mutagenesis: an overview.
    Ling MM; Robinson BH
    Anal Biochem; 1997 Dec; 254(2):157-78. PubMed ID: 9417773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of 81 of 81 known mouse beta-globin promoter mutations with T4 endonuclease VII--the EMC method.
    Youil R; Kemper B; Cotton RG
    Genomics; 1996 Mar; 32(3):431-5. PubMed ID: 8838807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.
    McKinzie PB; Delongchamp RR; Heflich RH; Parsons BL
    Mutat Res; 2001 Oct; 489(1):47-78. PubMed ID: 11673089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncomutations as biomarkers of cancer risk.
    Parsons BL; Myers MB; Meng F; Wang Y; McKinzie PB
    Environ Mol Mutagen; 2010; 51(8-9):836-50. PubMed ID: 20740637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial enrichment of heteroduplex DNA using a MutS-magnetic bead system.
    Murphy ZR; Shields DA; Evrony GD
    Biotechnol J; 2023 Jan; 18(1):e2200323. PubMed ID: 36317440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic methods for mutation scanning.
    Taylor GR; Deeble J
    Genet Anal; 1999 Feb; 14(5-6):181-6. PubMed ID: 10084112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fidelity and mutational spectrum of Pfu DNA polymerase on a human mitochondrial DNA sequence.
    André P; Kim A; Khrapko K; Thilly WG
    Genome Res; 1997 Aug; 7(8):843-52. PubMed ID: 9267808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and mapping of mismatched base pairs in DNA molecules by atomic force microscopy.
    Tanigawa M; Gotoh M; Machida M; Okada T; Oishi M
    Nucleic Acids Res; 2000 May; 28(9):E38. PubMed ID: 10756205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.